In individuals with type 2 diabetes, weight gain during treatment with insulin and other agents prevents the attainment of glycemic targets and probably limits the success of treatment. Studies have attempted to elucidate the mechanisms behind the apparent paradox of insulin improving glycemic control and cardiovascular risks, while causing weight gain. The aim of this study is to clarify the influence of insulin therapy on body weight and differential fat distribution (visceral or peripheral) in newly insulin treated type 2 diabetic male patients. Patients and Methods: The study was conducted on 26 type 2 diabetic male patients evaluated at baseline and 12 months after instituting insulin therapy. Body mass index (BMI), absolute waist circumference (AWC), systolic and diastolic blood pressure, HbA1c% was estimated. Abdominal Computed tomography was applied to evaluate areas of subcutaneous fat (SF) and visceral fat (VF) before and after insulin therapy. Results: There is significant reduction in HbA1c (9.03±0.72 vs. 7.50±0.58, p